Dendrimers target the ischemic lesion in rodent and primate models of nonarteritic anterior ischemic optic neuropathy

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Guo, Yan ^a   Johnson, Mary A ^a   Mehrabian, Zara ^a   Mishra, Manoj K ^b   Kannan, Rangaramanujam ^b   Miller, Neil R ^b   Bernstein, Steven L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANINE DYE 5; DENDRIMER; NANOPARTICLE; POLYAMIDOAMINE; CARBOCYANINE; DRUG CARRIER; FLUORESCENT DYE; POLYAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ARTICLE; CELL TRACKING; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENCE ANALYSIS; MALE; NONHUMAN; OUTCOME ASSESSMENT; RAT; RHESUS MONKEY; SIGNAL DETECTION; ANIMAL; ASTROCYTE; CHEMISTRY; DISEASE MODEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; ISCHEMIC OPTIC NEUROPATHY; LONG EVANS RAT; MACROPHAGE; METABOLISM; MOLECULARLY TARGETED THERAPY; OPTIC NERVE; PARTICLE SIZE; PATHOLOGY; SYNTHESIS;

ANIMALS; ASTROCYTES; CARBOCYANINES; DENDRIMERS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FLUORESCENT DYES; HUMANS; INJECTIONS, INTRAVENOUS; INTRAVITREAL INJECTIONS; MACACA MULATTA; MACROPHAGES; MALE; MOLECULAR TARGETED THERAPY; NANOPARTICLES; OPTIC NERVE; OPTIC NEUROPATHY, ISCHEMIC; PARTICLE SIZE; POLYAMINES; RATS; RATS, LONG-EVANS;

EID: 84966429099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154437     Document Type: Article

References (25)

1. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994; 14:38-44. PMID: 8032479
2. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123:103-107. PMID: 9186104
3. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003; 23:157-63. PMID: 12782932
4. Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003; 110:2031-35. PMID: 14522783
5. Salgado C, Vilson F, Miller NR, Bernstein SL. Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch Ophthalmol. 2011; 129:1583-91. doi: 10.1001/archophthalmol.2011.351 PMID: 22159678
6. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 1994; 14:66-69. PMID: 7951929
7. Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye. 2014; 29:65-79. doi: 10.1038/eye.2014.144 PMID: 24993324
8. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1029-46. doi: 10.1007/s00417-008-0805-8 PMID: 18404273
9. Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2003; 44:4153-62. PMID: 14507856
10. Chen CS, Johnson MA, Flower RA, Slater BJ, Miller NR, Bernstein SL. A Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy (pNAION). Invest Ophthalmol Vis Sci. 2008; 49:2985-92. doi: 10.1167/iovs.07-1651 PMID: 18326695
11. Nicholson JD, Puche AC, Guo Y, Weinreich D, Slater BJ, Bernstein SL. PGJ2 Provides Prolonged CNS Stroke Protection by Reducing White Matter Edema. PLoS One. 2012; 7:e50021. doi: 10.1371/journal.pone.0050021 PMID: 23284631
12. Zhang C, Guo Y, Miller NR, Bernstein SL. Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res. 2009; 1264:67-75. doi: 10.1016/j.brainres.2008.12.075 PMID: 19401181
13. Denes A, Ferenczi S, Kovacs KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011; 8:164. doi: 10.1186/1742-2094-8-164 PMID: 22114895
14. 2 in a rodent model of anterior ischemic optic neuoropathy. Invest Ophthalmol Vis Sci. 2013; 54:7402-7409. doi: 10.1167/iovs.13-12055 PMID: 24106118
15. 2 in a Non-Human Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophth Vis Sci. 2014; 55:7047-56.
16. Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Intern Med. 2014; 276:579-617. doi: 10.1111/joim.12280 PMID: 24995512
17. Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, et al. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med. 2012; 4:130ra46. doi: 10.1126/scitranslmed.3003162 PMID: 22517883
18. Mishra MK, Beaty CA, Lesniak WG, Kamhampati SP, Zhang F, Wilson MA, et al. Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano. 2014; 8:2134-47. doi: 10.1021/nn404872e PMID: 24499315
19. Wang B, Navath RS, Romero R, Kannan S, Kannan R. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm. 2009; 377:159-68. doi: 10.1016/j.ijpharm.2009.04.050 PMID: 19463931
20. Iezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials. 2012; 33:979-88. doi: 10.1016/j.biomaterials.2011.10.010 PMID: 22048009
21. Lesniak WG, Mishra MK, Jyoti A, Balakrishnan B, Zhang F, Nance E, et al. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm. 2013; 10:4560-71. doi: 10.1021/mp400371r PMID: 24116950
22. Sofroniew MV, Vinters HV. Astrocytes: Biology and Pathology. Acta Neuropathologica. 2010; 119:7-35. doi: 10.1007/s00401-009-0619-8 PMID: 20012068
23. Kambhampati SP, Kannan RM. Dendrimer nanoparticles for ocular drug delivery. J Ocul Pharmacol Ther. 2013; 29:151-65. doi: 10.1089/jop.2012.0232 PMID: 23410062
24. Rutar M, Natoli R, Chia RX, Valter K, Provis JM. Chemokine-mediated inflammation in the degenerating retina is coordinated by Muller cells, activated microglia, and retinal pigment epithelium. J Neuroinflammation. 2015;2015; 12:8. doi: 10.1186/s12974-014-0224-1 PMID: 25595590
25. Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells. Eur J Pharm Biopharm. 2015; 95(Pt B):239-49. doi: 10.1016/j.ejpb.2015.02.013 PMID: 25701805